KLS Keeping Law Simple Legislation in plain English

Straight-ahead summaries built from the official bill text. We keep the source links front and center and leave the decision up to you.

Back to Virginia

SB706 • 2026

Opioid antagonist; distribution program, reports.

An Act to amend the Code of Virginia by adding a section numbered 32.1-45.5, relating to Department of Health; opioid antagonist distribution program; reports.

Budget
Enacted

This bill passed the Legislature and reached final enactment based on the latest official action.

Sponsor
Srinivasan
Last action
2026-04-22
Official status
Acts of Assembly Chapter
Effective date
Not listed

Plain English Breakdown

Using official source text because the generated explanation was unavailable or could not be confirmed against the official bill text.

Opioid antagonist; distribution program, reports.

Department of Health; opioid antagonist distribution program; reports.

What This Bill Does

  • Department of Health; opioid antagonist distribution program; reports.
  • Directs the Department of Health to maintain a list of agencies and organizations that submit requests for and receive opioid antagonists through its distribution program and requires the Department to submit a quarterly report to the Chairs of the House Appropriations Subcommittee on Health and Human Resources, House Health and Human Services Committee, Senate Finance and Appropriations Subcommittee on Health and Human Resources, and Senate Subcommittee on Health, and the chair of the Virginia Opioid Abatement Authority on its distribution of opioid antagonists.
  • The bill requires the Department to submit an annual report to the Joint Commission on Health Care and the Chairs of the House Appropriations Committee and the Senate Finance and Appropriations Committee by December 1 of each year estimating the costs of the opioid antagonist distribution program for the following fiscal year using a methodology developed by the Department pursuant to parameters set out in the bill.
  • This bill is a recommendation of the Joint Commission on Health Care.

Limits and Unknowns

  • This entry is temporarily using official source text because the generated explanation could not be confirmed against the official bill text during the last sync.

Amendments

These notes stay tied to the official amendment files and metadata from the legislature.

SB706G

2026-04-11 • Governor

Governor's Recommendation

Plain English: (SB706) GOVERNOR'S RECOMMENDATION I approve the general purpose of this bill, but I am returning it without my signature with the request that the attached Amendment in the Nature of a Substitute (26108868D) be accepted.

  • (SB706) GOVERNOR'S RECOMMENDATION I approve the general purpose of this bill, but I am returning it without my signature with the request that the attached Amendment in the Nature of a Substitute (26108868D) be accepted.
SB706S1

2026-04-13 • Governor

Governor Substitute

Plain English: 2026 SESSION SENATE SUBSTITUTE 26108868D SENATE BILL NO.

  • 2026 SESSION SENATE SUBSTITUTE 26108868D SENATE BILL NO.
  • 706 AMENDMENT IN THE NATURE OF A SUBSTITUTE (Proposed by the Governor on April 11, 2026) (Patron Prior to Substitute—Senator Srinivasan) A BILL to amend the Code of Virginia by adding a section numbered 32.1-45.5 , relating to Department of Health; opioid antagonist distribution program; reports.
  • Be it enacted by the General Assembly of Virginia: 1.
  • That the Code of Virginia is amended by adding a section numbered 32.1-45.5 as follows: § 32.1-45.5 .

Bill History

  1. 2026-04-22 Governor

    Governor's recommendation adopted

  2. 2026-04-22 House

    Signed by Speaker

  3. 2026-04-22 Senate

    Signed by President

  4. 2026-04-22 Governor

    Approved by Governor-Chapter 1024 (effective 7/1/2026)

  5. 2026-04-22 Senate

    Reenrolled

  6. 2026-04-22 Senate

    Reenrolled bill text (SB706ER2)

  7. 2026-04-22 Governor

    Acts of Assembly Chapter text (CHAP1024)

  8. 2026-04-22 Senate

    Senate concurred in Governor's recommendation (39-Y 0-N 0-A)

  9. 2026-04-22 House

    House concurred in Governor's recommendation (98-Y 0-N 0-A)

  10. 2026-04-11 Governor

    Governor's recommendation received by Senate (SB706G)

  11. 2026-03-10 Senate

    Enrolled Bill communicated to Governor on March 10, 2026

  12. 2026-03-10 Governor

    Governor's Action Deadline 11:59 p.m., April 13, 2026

  13. 2026-02-26 House

    Signed by Speaker

  14. 2026-02-26 Senate

    Signed by President

  15. 2026-02-26 Senate

    Enrolled

  16. 2026-02-26 Senate

    Bill text as passed Senate and House (SB706ER)

  17. 2026-02-26 Senate

    Fiscal Impact Statement from Department of Planning and Budget (SB706)

  18. 2026-02-24 House

    Read third time

  19. 2026-02-24 House

    Passed House Block Vote (98-Y 0-N 0-A)

  20. 2026-02-23 House

    Read second time

  21. 2026-02-19 Health and Human Services

    Reported from Health and Human Services (21-Y 0-N)

  22. 2026-02-09 House

    Placed on Calendar

  23. 2026-02-09 House

    Read first time

  24. 2026-02-09 Health and Human Services

    Referred to Committee on Health and Human Services

  25. 2026-02-03 Senate

    Read third time and passed Senate Block Vote (39-Y 0-N 0-A)

  26. 2026-02-02 Senate

    Read second time

  27. 2026-02-02 Senate

    Engrossed by Senate

  28. 2026-02-02 Senate

    Engrossed by Senate Block Vote (Voice Vote)

  29. 2026-01-30 Senate

    Rules suspended

  30. 2026-01-30 Senate

    Passed by for the day

  31. 2026-01-30 Senate

    Constitutional reading dispensed Block Vote (on 1st reading) (38-Y 0-N 0-A)

  32. 2026-01-30 Senate

    Passed by for the day Block Vote (Voice Vote)

  33. 2026-01-29 Education and Health

    Reported from Education and Health (15-Y 0-N)

  34. 2026-01-27 Health

    Assigned Education sub: Health

  35. 2026-01-26 Senate

    Fiscal Impact Statement from Department of Planning and Budget (SB706)

  36. 2026-01-14 Senate

    Prefiled and ordered printed; Offered 01-14-2026 26103585D

  37. 2026-01-14 Education and Health

    Referred to Committee on Education and Health

Official Summary Text

Department of Health; opioid antagonist distribution program; reports.
Directs the Department of Health to maintain a list of agencies and organizations that submit requests for and receive opioid antagonists through its distribution program and requires the Department to submit a quarterly report to the Chairs of the House Appropriations Subcommittee on Health and Human Resources, House Health and Human Services Committee, Senate Finance and Appropriations Subcommittee on Health and Human Resources, and Senate Subcommittee on Health, and the chair of the Virginia Opioid Abatement Authority on its distribution of opioid antagonists. The bill requires the Department to submit an annual report to the Joint Commission on Health Care and the Chairs of the House Appropriations Committee and the Senate Finance and Appropriations Committee by December 1 of each year estimating the costs of the opioid antagonist distribution program for the following fiscal year using a methodology developed by the Department pursuant to parameters set out in the bill. This bill is a recommendation of the Joint Commission on Health Care.

Current Bill Text

Read the full stored bill text 
An Act to amend the Code of Virginia by adding a section numbered
32.1-45.5
, relating to Department of Health; opioid antagonist distribution program; reports.
Be it enacted by the General Assembly of Virginia:
1. That the Code of Virginia is amended by adding a section numbered
32.1-45.5
as follows:
§
32.1-45.5
. Opioid antagonist distribution program; reports.
A. The Department shall maintain a list of all agencies and organizations that submit requests for and receive opioid antagonists through its distribution program. At least quarterly, the Department shall submit a report to the Chairs of the House Committee on Appropriations, the House Committee on Health and Human Services, the Senate Committee on Finance and Appropriations, and the Senate Committee on Education and Health and the chair of the Virginia Opioid Abatement Authority with the following information: (i) the name of the agency or organization; (ii) the county, city, or town service area; (iii) the quantity, along with the specific formulation and dosage of opioid antagonist, requested by the agency or organization in its most recent order, and the date the request was made; and (iv) the quantity, along with the specific formulation and dosage of opioid antagonist, received by the agency or organization in response to its most recent order, and the date the request was fulfilled.
B. The Department shall develop a methodology to estimate annual opioid antagonist distribution program costs. In developing such methodology, the Department shall use available data and consider account saturation goals, community needs, local resources, and the costs of products. The Department shall submit an annual report estimating the opioid antagonist distribution program costs for the following fiscal year using such methodology to the Joint Commission on Health Care and the Chairs of the House Committee on Appropriations and the Senate Committee on Finance and Appropriations by December 1 of each year.